Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 149, Issue , 2015, Pages 118-127

  Chen, Zhike ^a   Wang, Yuanzhong ^a   Warden, Charles ^a   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase inhibitor resistance; Breast cancer; c MYC; ER; Glutamine; HER2

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUTAMINE; MYC PROTEIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ERBB2 PROTEIN, HUMAN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; FULVESTRANT;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METABOLISM; MOLECULAR INTERACTION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; MOLECULARLY TARGETED THERAPY;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMINE; HUMANS; MCF-7 CELLS; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2;

EID: 84923224172     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.02.004     Document Type: Article

References (37)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. D. Mauri, N. Pavlidis, N.P. Polyzos, and J.P. Ioannidis Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis J. Natl. Cancer Inst. 98 2006 1285 1291
3. L.A. Martin, I. Farmer, S.R. Johnston, S. Ali, C. Marshall, and M. Dowsett Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation J. Biol. Chem. 278 2003 30458 30468
4. D. Jelovac, G. Sabnis, B.J. Long, L. Macedo, O.G. Goloubeva, and A.M. Brodie Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole Cancer Res. 65 2005 5380 5389
5. E. Tokunaga, Y. Kimura, K. Mashino, E. Oki, A. Kataoka, S. Ohno, M. Morita, Y. Kakeji, H. Baba, and Y. Maehara Activation of PI3K/Akt signaling and hormone resistance in breast cancer Breast Cancer 13 2006 137 144
6. M.H. Flageng, L.L. Moi, J.M. Dixon, J. Geisler, E.A. Lien, W.R. Miller, P.E. Lonning, and G. Mellgren Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors Br. J. Cancer 101 2009 1253 1260
7. R.A. Campbell, P. Bhat-Nakshatri, N.M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J. Biol. Chem. 276 2001 9817 9824
8. S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 1995 1491 1494
9. S. Masri, S. Phung, X. Wang, X. Wu, Y.C. Yuan, L. Wagman, and S. Chen Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor Cancer Res. 68 2008 4910 4918
10. L.A. Martin, I. Farmer, S.R. Johnston, S. Ali, and M. Dowsett Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation Endocr. Relat. Cancer 1 Suppl. 12 2005 S75 84
11. R.J. Santen, R.X. Song, Z. Zhang, R. Kumar, M.H. Jeng, A. Masamura, J. Lawrence Jr., L. Berstein, and W. Yue Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity Endocr. Relat. Cancer 12 Suppl. 1 2005 S61 S73
12. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
13. C. Wang, J.A. Mayer, A. Mazumdar, K. Fertuck, H. Kim, M. Brown, and P.H. Brown Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor Mol. Endocrinol. 25 2011 1527 1538
14. C. Grandori, S.M. Cowley, L.P. James, and R.N. Eisenman The Myc/Max/Mad network and the transcriptional control of cell behavior Ann. Rev. Cell Dev. Biol. 16 2000 653 699
15. T.W. Miller, J.M. Balko, Z. Ghazoui, A. Dunbier, H. Anderson, M. Dowsett, A.M. Gonzalez-Angulo, G.B. Mills, W.R. Miller, H. Wu, Y. Shyr, and C.L. Arteaga A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance Clin. Cancer Res. 17 2011 2024 2034
16. C.M. McNeil, C.M. Sergio, L.R. Anderson, C.K. Inman, S.A. Eggleton, N.C. Murphy, E.K. Millar, P. Crea, J.G. Kench, M.C. Alles, M. Gardiner-Garden, C.J. Ormandy, A.J. Butt, S.M. Henshall, E.A. Musgrove, and R.L. Sutherland c-Myc overexpression and endocrine resistance in breast cancer J. Steroid Biochem. Mol. Biol. 102 2006 147 155
17. D. Al-azawi, M.M. Ilroy, G. Kelly, A.M. Redmond, F.T. Bane, S. Cocchiglia, A.D. Hill, and L.S. Young Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer Oncogene 27 2008 3021 3031
18. A.N. Shajahan-Haq, K.L. Cook, J.L. Schwartz-Roberts, A.E. Eltayeb, D.M. Demas, A.M. Warri, C.O. Facey, L.A. Hilakivi-Clarke, and R. Clarke MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer Mol. Cancer 13 2014 239
19. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab. 7 2008 11 20
20. D.R. Wise, and C.B. Thompson Glutamine addiction: a new therapeutic target in cancer Trends Biochem. Sci. 35 2010 427 433
21. N.S. Forbes, A.L. Meadows, D.S. Clark, and H.W. Blanch Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis Metab. Eng. 8 2006 639 652
22. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, and C.B. Thompson Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. U. S. A. 105 2008 18782 18787
23. P. Gao, I. Tchernyshyov, T.C. Chang, Y.S. Lee, K. Kita, T. Ochi, K.I. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, and C.V. Dang c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
24. D.J. Zhou, D. Pompon, and S.A. Chen Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening Cancer Res. 50 1990 6949 6954
25. A. Spandidos, X. Wang, H. Wang, and B. Seed PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification Nucleic Acids Res. 38 2010 D792 799
26. Z. Chen, O. Wang, M. Nie, K. Elison, D. Zhou, M. Li, Y. Jiang, W. Xia, X. Meng, S. Chen, and X. Xing Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism Mol. Cell. Endocrinol. 399 2015 32 42
27. C. Trapnell, L. Pachter, and S.L. Salzberg TopHat: discovering splice junctions with RNA-Seq Bioinformatics 25 2009 1105 1111
28. A. Mortazavi, B.A. Williams, K. McCue, L. Schaeffer, and B. Wold Mapping and quantifying mammalian transcriptomes by RNA-Seq Nat. Methods 5 2008 621 628
29. K.D. Pruitt, T. Tatusova, G.R. Brown, and D.R. Maglott NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy Nucleic Acids Res. 40 2012 D130 D135
30. Y. Xing, T. Yu, Y.N. Wu, M. Roy, J. Kim, and C. Lee An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs Nucleic Acids Res. 34 2006 3150 3160
31. C.D. Warden, Y.-C. Yuan, and X. Wu Optimal calculation of RNA-Seq fold-change values Int. J. Comput. Bioinfo. In Silico Model 2 2013 285 292
32. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc. Series B (Methodological) 57 1995 289 300
33. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat. Rev. Mol. Cell Biol. 2 2001 127 137
34. N.P. Shanware, A.R. Mullen, R.J. DeBerardinis, and R.T. Abraham Glutamine: pleiotropic roles in tumor growth and stress resistance J. Mol. Med. 89 2011 229 236
35. J.Q. Chen, T.R. Brown, and J. Russo Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors Biochim. Biophys. Acta 1793 2009 1128 1143
36. J. Blancato, B. Singh, A. Liu, D.J. Liao, and R.B. Dickson Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses Br. J. Cancer 90 2004 1612 1619
37. P. Nicklin, P. Bergman, B. Zhang, E. Triantafellow, H. Wang, B. Nyfeler, H. Yang, M. Hild, C. Kung, C. Wilson, V.E. Myer, J.P. MacKeigan, J.A. Porter, Y.K. Wang, L.C. Cantley, P.M. Finan, and L.O. Murphy Bidirectional transport of amino acids regulates mTOR and autophagy Cell 136 2009 521 534